论文部分内容阅读
几乎所有的终末期肾病（ESRD）均存在有继发性甲状旁腺机能亢进（SHP：［，）和肾性骨病，透析疗法不能改善其发生发展。本文对我院1994年以来的12例（3888例次）无醋酸盐血液透析（AFHD）和IO例（3240例次）重碳酸盐血液透析·（BHD）患者的甲状旁腺素（i－ITIH）。钙磷代谢、
Almost all patients with end-stage renal disease (ESRD) have secondary hyperparathyroidism (SHP) and renal osteodystrophy, and dialysis does not improve their development. In this paper, 12 cases (3888 cases) of parathyroid hormone (imatinib) in patients with AFHD and 10 cases (3240 cases) of bicarbonate hemodialysis (BHD) -ITIH). Calcium phosphorus metabolism,